FDA Approves First Dietary Supplement under New Drug Application with the Indication of Serious or Life-Threatening Illnesses

ISSN Print: 2157-9423
ISSN Online: 2157-9431
www.scirp.net/journal/pp
E-mail: [email protected]

Citations

"FDA Approves First Dietary Supplement under New Drug Application with the Indication of Serious or Life-Threatening Illnesses"
written by Huu S. Tieu, Martin F. Loeffler,
published by Pharmacology & Pharmacy, Vol.13 No.12, 2022

has been cited by the following article(s):

No relevant information.

[1]	Tiêu Equation Experimentation of Understanding by Energy Transfer Quantum Mechanics Natural Science, 2023 DOI:10.4236/ns.2023.153008

[2]	Huu S. TIEU’s Predicting Outcome of Severe Acute Respiratory Syndrome (SARS) and Preparing the Treatment for COVID-19 (Coronavirus) and Other Viral Pandemics International Journal of Clinical Medicine, 2023 DOI:10.4236/ijcm.2023.142008

[3]	Huu S. TIEU Request for FDA to Establish Regenerating Human Cells as Law on December 13, 2016 President Barack H. Obama Signed the 21st Century CURES Act into FDA Regulation and Law Open Journal of Regenerative Medicine, 2022 DOI:10.4236/ojrm.2022.113004